VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxpresso
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Last Month

From Jan 01, 2012 To Jan 31, 2012 :


Bacillus anthracis (Anthrax)

  1. Liao Q, Strong AJ, Liu Y, Liu Y, Meng P, Fu Y, Touzjian N, Shao Y, Zhao Z, Lu Y. HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques Vaccine 2012 [PMID: 22261410]
  2. Stewart B, Zhang Y, Rose Jr CE, Tokars JI, Martin SW, Franzke LH, McNeil MM. Health-related quality of life in the Anthrax Vaccination Program for workers in the Laboratory Response Network Vaccine 2012 [PMID: 22230591]
  3. Liu X, Wang D, Wang H, Feng E, Zhu L, Wang H. Curing of Plasmid pXO1 from Bacillus anthracis Using Plasmid Incompatibility PloS one 7(1):e29875 2012 [PMID: 22253811]

Brucella (Brucellosis)

  1. Nardi Júnior G, Ribeiro MG, Jorge AM, Megid J, Silva LM. Serological profile of buffalo (Bubalus bubalis) female calves vaccinated with standard Brucella abortus strain 19 vaccine using rose bengal, 2-mercaptoethanol and complement fixation tests Biologicals : journal of the International Association of Biological Standardization 2012 [PMID: 22284623]
  2. Iwashkiw JA, Fentabil MA, Faridmoayer A, Mills DC, Peppler M, Czibener C, Ciocchini AE, Comerci DJ, Ugalde JE, Feldman MF. Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis Microbial cell factories 11(1):13 2012 [PMID: 22276812]
  3. Surendran N, Hiltbold EM, Heid B, Akira S, Standiford TJ, Sriranganathan N, Boyle SM, Zimmerman KL, Makris MR, Witonsky SG. Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo Vaccine 2012 [PMID: 22234268]
  4. Sáez D, Fernández P, Rivera A, Andrews E, Oñate A. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity Vaccine 2012 [PMID: 22222868]
  5. Wang F, Hu S, Liu W, Qiao Z, Gao Y, Bu Z. Deep-Sequencing Analysis of the Mouse Transcriptome Response to Infection with Brucella melitensis Strains of Differing Virulence PloS one 6(12):e28485 2011 [PMID: 22216095]

Burkholderia pseudomallei (Melioidosis)

  1. Panomket P. Immune response to Burkholderia pseudomallei Journal of the Medical Association of Thailand = Chotmaihet thangphaet 94(11):1410-1417 2011 [PMID: 22256484]

Clostridium botulinum toxin (Botulism)

  1. Shearer JD, Manetz TS, House RV. Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B) Vaccine 2012 [PMID: 22269871]

Clostridium perfringens

  1. Pegu P, Helmus R, Gupta P, Tarwater P, Caruso L, Shen C, Ross T, Chen Y. Induction of Strong Anti-HIV Cellular Immunity by a Combination of Clostridium Perfringens Expressing HIV Gag and Virus Like Particles Current HIV research 2011 [PMID: 22211658]

Coxiella burnetii (Q fever)

  1. Schimmer B, Luttikholt S, Hautvast JL, Graat EA, Vellema P, van Duynhoven YT. Seroprevalence and risk factors of Q fever in goats on commercial dairy goat farms in the Netherlands, 2009-2010 BMC veterinary research 7(1):81 2011 [PMID: 22208798]

Eastern equine encephalitis virus

  1. Pandya J, Gorchakov R, Wang E, Leal G, Weaver SC. A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation Vaccine 2012 [PMID: 22222869]

Ebola virus

  1. Ou W, Delisle J, Jacques J, Shih J, Price G, Kuhn JH, Wang V, Verthelyi D, Kaplan G, Wilson CA. Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain Virology journal 9(1):32 2012 [PMID: 22273269]
  2. Marzi A, Feldmann H, Geisbert TW, Falzarano D. Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections Journal of bioterrorism & biodefense S1(4) 2011 [PMID: 22288023]
  3. Warfield KL, Olinger GG. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic Fever Journal of biomedicine & biotechnology 2011:984241 2011 [PMID: 22253531]
  4. Ryan SJ, Walsh PD. Consequences of non-intervention for infectious disease in african great apes PloS one 6(12):e29030 2011 [PMID: 22216162]

Escherichia coli

  1. Nguyen AH, Molineux IJ, Springman R, Bull JJ. Multiple genetic pathways to similar fitness limits during viral adaptation to a new host Evolution; international journal of organic evolution 66(2):363-374 2012 [PMID: 22276534]
  2. Wang YS, Ouyang W, Liu XJ, He KW, Yu SQ, Zhang HB, Fan HJ, Lu CP. Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV Vaccine 2012 [PMID: 22285269]
  3. Hu YH, Dang W, Deng T, Sun L. Edwardsiella tarda DnaK: Expression, activity, and the basis for the construction of a bivalent live vaccine against E. tarda and Streptococcus iniae Fish & shellfish immunology 2012 [PMID: 22281608]
  4. Morley EJ, Lapoint JM, Roy LW, Cantor R, Grant WD, Paolo WF, Wojcik S. Rates of Positive Blood, Urine, and Cerebrospinal Fluid Cultures in Children Younger Than 60 Days During the Vaccination Era Pediatric emergency care 2012 [PMID: 22270498]
  5. Liu J, Wang WD, Liu YJ, Liu S, Zhou B, Zhu LW, Ji X, Sun Y, Feng SZ. Mice vaccinated with enteropathogenic Escherichia coli ghosts show significant protection against lethal challenges Letters in applied microbiology 2012 [PMID: 22257028]
  6. Gunther J, Petzl W, Zerbe H, Schuberth HJ, Koczan D, Goetze L, Seyfert HM. Lipopolysaccharide priming enhances expression of effectors of immune defence while decreasing expression of pro-inflammatory cytokines in mammary epithelia cells from cows BMC genomics 13(1):17 2012 [PMID: 22235868]
  7. Huang X, Li J, Zhang G, Gong P, Yang J, Zhang X. Toxoplasma gondii: Protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB/c mice Experimental parasitology 2012 [PMID: 22248986]
  8. Li-Li Z, Min L, Jun-Wei G, Xin-Yuan Q, Yi-Jing L, Di-Qiu L. Expression of infectious pancreatic necrosis virus (IPNV) VP2-VP3 fusion protein in Lactobacillus casei and immunogenicity in rainbow trouts Vaccine 2012 [PMID: 22234263]
  9. Silva F, Queiroz JA, Domingues FC. Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli Biotechnology advances 2012 [PMID: 22244816]
  10. Yang J, Mao M, Zhang S, Li H, Jiang Z, Cao G, Cao D, Wang X, Zhang L. Innate defense regulator peptide synergizes with CpG ODN for enhanced innate intestinal immune responses in neonate piglets International immunopharmacology 2012 [PMID: 22226751]
  11. Sabui S, Dutta S, Debnath A, Ghosh A, Hamabata T, Rajendran K, Ramamurthy T, Nataro JP, Sur D, Levine MM, Chatterjee NS. Real Time PCR-based Mismatch Amplification Mutation Assay for the Specific Detection of CS6-expressing Allelic Variants of Enterotoxigenic Escherichia coli and its Application in Assessing Diarrheal Cases and Asymptomatic Controls Journal of clinical microbiology 2012 [PMID: 22219305]
  12. Yang X, Suo Z, Thornburg T, Holderness K, Cao L, Lim T, Walters N, Kellerman L, Loetterle L, Avci R, Pascual DW. Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella Virulence 3(1) 2012 [PMID: 22286706]
  13. El-Attar LM, Scott S, Goh S, Good L. A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker Vaccine 2011 [PMID: 22212129]
  14. Reis JK, Diniz RS, Haddad JP, Ferraz IB, Carvalho AF, Kroon EG, Ferreira PC, Leite RC. Recombinant envelope protein (rgp90) ELISA for equine infectious anemia virus provides comparable results to the agar gel immunodiffusion Journal of virological methods 2011 [PMID: 22227617]
  15. Liu J, Wang WD, Liu YJ, Liu S, Zhou B, Zhu LW, Ji X, Sun Y, Feng SZ. Mice vaccinated with enteropathogenic Escherichia coli ghosts show significant protection against lethal challenges Letters in applied microbiology 2011 [PMID: 22211792]
  16. Liu J, Chen Y, Yuan F, Hu L, Bei W, Chen H. Cloning, expression, and characterization of TonB2 from Actinobacillus pleuropneumoniae and potential use as an antigenic vaccine candidate and diagnostic marker Canadian journal of veterinary research = Revue canadienne de recherche veterinaire 75(3):183-190 2011 [PMID: 22210994]
  17. Wisner AL, Potter AA, Köster W. Effect of the Salmonella Pathogenicity Island 2 Type III Secretion System on Salmonella Survival in Activated Chicken Macrophage-Like HD11 Cells PloS one 6(12):e29787 2011 [PMID: 22216355]

Francisella tularensis (Tularemia)

  1. Kaur R, Chen S, Arévalo MT, Xu Q, Chen Y, Zeng M. Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis Clinical and vaccine immunology : CVI 2012 [PMID: 22278325]
  2. Honn M, Lindgren H, Sjostedt A. The role of MglA for adaptation to oxidative stress of Francisella tularensis LVS BMC microbiology 12(1):14 2012 [PMID: 22264342]
  3. De Pascalis R, Chou AY, Bosio CM, Huang CY, Follmann DA, Elkins KL. Development of Functional and Molecular Correlates of Vaccine-Induced Protection for a Model Intracellular Pathogen, F. tularensis LVS PLoS pathogens 8(1):e1002494 2012 [PMID: 22275868]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Cottingham MG, Carroll F, Morris SJ, Turner AV, Vaughan AM, Kapulu MC, Colloca S, Siani L, Gilbert SC, Hill AV. Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors Biotechnology and bioengineering 109(3):719-728 2012 [PMID: 22252512]
  2. Chiriva-Internati M, Kast WM, Bot A. In this Issue: Targeting Human Papilloma Virus-Associated Disease, from Cervical to Head and Neck Carcinoma… and more International reviews of immunology 31(1):1-2 2012 [PMID: 22251004]
  3. Price MA, Rida W, Mwangome M, Mutua G, Middelkoop K, Roux S, Okuku HS, Bekker LG, Anzala O, Ngugi E, Stevens G, Chetty P, Amornkul PN, Sanders EJ. Identifying At-Risk Populations in Kenya and South Africa: HIV Incidence in Cohorts of Men Who Report Sex With Men, Sex Workers, and Youth Journal of acquired immune deficiency syndromes (1999) 59(2):185-193 2012 [PMID: 22227488]
  4. Jafari HS. Commentary: Immunologic Response to Oral Polio Vaccine in Human Immunodeficiency Virus-infected and Uninfected Zimbabwean Children The Pediatric infectious disease journal 31(2):181-183 2012 [PMID: 22252205]
  5. Chen W, Streaker ED, Russ DE, Feng Y, Prabakaran P, Dimitrov DS. Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens Biochemical and biophysical research communications 417(4):1164-1169 2012 [PMID: 22226962]
  6. Voskens CJ, Sewell D, Hertzano R, Desanto J, Rollins S, Lee M, Taylor R, Wolf J, Suntharalingam M, Gastman B, Papadimitriou JC, Lu C, Tan M, Morales R, Cullen K, Celis E, Mann D, Strome SE. inducTION of mage-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma Head & neck 2012 [PMID: 22287423]
  7. Shukla NM, Mutz CA, Malladi SS, Warshakoon HJ, Balakrishna R, David SA. Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines Journal of medicinal chemistry 2012 [PMID: 22239408]
  8. Duenas-Decamp MJ, O'Connell OJ, Corti D, Zolla-Pazner S, Clapham PR. The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodies Retrovirology 9(1):9 2012 [PMID: 22284192]
  9. Scriba TJ, Tameris M, Smit E, van der Merwe L, Hughes EJ, Kadira B, Mauff K, Moyo S, Brittain N, Lawrie A, Mulenga H, de Kock M, Makhethe L, van Rensburg EJ, Gelderbloem S, Veldsman A, Hatherill M, Geldenhuys H, Hill AV, Hawkridge A, Hussey GD, Hanekom WA, McShane H, Mahomed H. A phase IIa Trial of the new TB Vaccine, MVA85A, in HIV and/or M. Tuberculosis Infected Adults American journal of respiratory and critical care medicine 2012 [PMID: 22281831]
  10. El Sahly HM, Davis C, Kotloff K, Meier J, Winokur PL, Wald A, Johnston C, George SL, Brady RC, Lehmann C, Stokes-Riner A, Keitel WA. Higher Antigen Content Improves the Immune Response to 2009 H1N1 Influenza Vaccine in HIV-Infected Adults: A Randomized Clinical Trial The Journal of infectious diseases 2012 [PMID: 22275399]
  11. Reading JL, Meyers AF, Vyakarnam A. Whey acidic proteins (WAPs): novel modulators of innate immunity to HIV infection Current opinion in HIV and AIDS 2012 [PMID: 22274658]
  12. Zhou M, Kostoula I, Brill B, Panou E, Sakarellos-Daitsiotis M, Dietrich U. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice Vaccine 2012 [PMID: 22269872]
  13. McCall-Hosenfeld JS, Weisman CS, Camacho F, Hillemeier MM, Chuang CH. Multilevel Analysis of the Determinants of Receipt of Clinical Preventive Services Among Reproductive-Age Women Women's health issues : official publication of the Jacobs Institute of Women's Health 2012 [PMID: 22269668]
  14. Palma P, Romiti ML, Bernardi S, Pontrelli G, Mora N, Santilli V, Tchidjou HK, Aquilani A, Cotugno N, Alghisi F, Lucidi V, Rossi P, Douagi I. Safety and immunogenicity of a monovalent MF59(®)-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults Biologicals : journal of the International Association of Biological Standardization 2012 [PMID: 22261282]
  15. Tortajada C, Garcia de Olalla P, Diez E, Pinto RM, Bosch A, Perez U, Sanz M, Cayla JA, Working Group S. Hepatitis A among men who have sex with men in Barcelona, 1989-2010: insufficient control and need for new approaches BMC infectious diseases 12(1):11 2012 [PMID: 22264382]
  16. Pacanowski J, Lacombe K, Campa P, Dabrowska M, Poveda JD, Meynard JL, Poirot JL, Fonquernie L, Girard PM. Plasma HIV-RNA is the key determinant of long-term antibody persistence following Yellow fever immunization in a cohort of 364 HIV-infected patients Journal of acquired immune deficiency syndromes (1999) 2012 [PMID: 22267015]
  17. Willer DO, Ambagala AP, Pilon R, Chan JK, Fournier J, Brooks J, Sandstrom P, Macdonald KS. Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with human Varicella Zoster Virus (VZV) Journal of virology 2012 [PMID: 22258257]
  18. Doria-Rose NA, Louder MK, Yang Z, O'Dell S, Nason M, Schmidt SD, McKee K, Seaman MS, Bailer RT, Mascola JR. HIV-1 Neutralization Coverage Is Improved by Combining Monoclonal Antibodies That Target Independent Epitopes Journal of virology 2012 [PMID: 22258252]
  19. Gaffga NH, Flagg EW, Weinstock HS, Shlay JC, Ghanem KG, Koutsky LA, Kerndt PR, Hsu KK, Unger ER, Datta SD. Monitoring HPV type-specific prevalence over time through clinic-based surveillance: A perspective on vaccine effectiveness Vaccine 2012 [PMID: 22265859]
  20. Dhalla S, Poole G, Singer J, Patrick DM, Kerr T. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users Psychology, health & medicine 2012 [PMID: 22250925]
  21. Liao Q, Strong AJ, Liu Y, Liu Y, Meng P, Fu Y, Touzjian N, Shao Y, Zhao Z, Lu Y. HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques Vaccine 2012 [PMID: 22261410]
  22. van der Kuyl AC. HIV infection and HERV expression: a review Retrovirology 9(1):6 2012 [PMID: 22248111]
  23. Young ND, Jex AR, Li B, Liu S, Yang L, Xiong Z, Li Y, Cantacessi C, Hall RS, Xu X, Chen F, Wu X, Zerlotini A, Oliveira G, Hofmann A, Zhang G, Fang X, Kang Y, Campbell BE, Loukas A, Ranganathan S, Rollinson D, Rinaldi G, Brindley PJ, Yang H, Wang J, Wang J, Gasser RB. Whole-genome sequence of Schistosoma haematobium Nature genetics 44(2):221-225 2012 [PMID: 22246508]
  24. Friis AM, Akerlund B, Gyllensten K, Aleman A, Ernberg I. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups Scandinavian journal of infectious diseases 2012 [PMID: 22243136]
  25. Buckheit Jr RW, Buckheit KW. An Algorithm for the Preclinical Development of Anti-HIV Topical Microbicides Current HIV research 2012 [PMID: 22264051]
  26. Eade CR, Wood MP, Cole AM. Mechanisms and Modifications of Naturally Occurring Host Defense Peptides for Anti-HIV Microbicide Development Current HIV research 2012 [PMID: 22264047]
  27. Herrera C, Shattock RJ. Potential use of protease inhibitors as vaginal and colorectal microbicides Current HIV research 2012 [PMID: 22264045]
  28. Crucittia GC, Botta M, Di Santoa R. Will Integrase Inhibitors be used as Microbicides? Current HIV research 2012 [PMID: 22264044]
  29. Gibson RM, Arts EJ. Past, Present, and Future of Entry Inhibitors as HIV Microbicides Current HIV research 2012 [PMID: 22264042]
  30. Romano JW, Robbiani M, Doncel G, Moench T. Non-Specific Microbicide Product Development: Then and Now Current HIV research 2012 [PMID: 22264041]
  31. Neogi U, Gupta S, Sahoo PN, Shet A, Rao SD, Ranga U, Prasad VR. Genetic characterization of HIV-1 Tat exon 1 from a southern Indian clinical cohort: identification of unique epidemiological signature residues AIDS research and human retroviruses 2012 [PMID: 22236201]
  32. Li L, Sun G, Li T, Liu Y, Chen L, Liu H, Cui W, Li H, Zhuang D, Wang Z, Li J. Multiple introductions of HIV into men who have sex with men were found in Zhengzhou city, China AIDS research and human retroviruses 2012 [PMID: 22236149]
  33. Ladak F, Gjelsvik A, Feller E, Rosenthal S, Montague BT. Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007 Infection 2012 [PMID: 22237474]
  34. Hemelaar J. The origin and diversity of the HIV-1 pandemic Trends in molecular medicine 2012 [PMID: 22240486]
  35. Duerr A. HIV treatment as protection: next steps Current opinion in HIV and AIDS 2012 [PMID: 22241162]
  36. De Rosa SC. Vaccine applications of flow cytometry Methods (San Diego, Calif.) 2012 [PMID: 22251671]
  37. Peña J, Frías M, Castro-Orgaz L, González R, García F, Gallart T, Gatell JM, Plana And The Dc2-Manon07 Vaccine Research Group M. Effects on Innate Immunity of a Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection Viral immunology 2012 [PMID: 22233253]
  38. Kurle S, Thakar M, Shete A, Paranjape R. In Vitro Sensitization of T Cells with DC-Associated/Delivered HIV Constructs Can Induce a Polyfunctional CTL Response, Memory T-Cell Response, and Virus Suppression Viral immunology 2012 [PMID: 22233251]
  39. Cox JH, Ferrari MG, Earl P, Lane JR, Jagodzinski LL, Polonis VR, Kuta EG, Boyer JD, Ratto-Kim S, Eller LA, Pham DT, Hart L, Montefiori D, Ferrari G, Parrish S, Weiner DB, Moss B, Kim JH, Birx D, Vancott TC. Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge Vaccine 2012 [PMID: 22234262]
  40. Rubio-Infante N, Govea-Alonso DO, Alpuche-Solís AG, García-Hernández AL, Soria-Guerra RE, Paz-Maldonado LM, Ilhuicatzi-Alvarado D, Varona-Santos JT, Verdín-Terán L, Korban SS, Moreno-Fierros L, Rosales-Mendoza S. A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice Plant molecular biology 2012 [PMID: 22228408]
  41. Ham AS, Ugaonkar SR, Shi L, Buckheit KW, Lakougna H, Nagaraja U, Gwozdz G, Goldman L, Kiser PF, Buckheit RW Jr. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection Journal of pharmaceutical sciences 2012 [PMID: 22227864]
  42. McBurney SP, Landucci G, Forthal DN, Ross TM. Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent clade B virus-like particle vaccine AIDS research and human retroviruses 2012 [PMID: 22214267]
  43. Mahnke YD, Greenwald JH, Dersimonian R, Roby G, Antonelli LR, Sher A, Roederer M, Sereti I. Selective expansion of polyfunctional pathogen-specific CD4+ T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome Blood 2012 [PMID: 22219223]
  44. Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials Lancet 2012 [PMID: 22225814]
  45. Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, Stablein D, Pau MG, Schuitemaker H, Sadoff JC, Billings EA, Rao M, Robb ML, Kim JH, Marovich MA, Goudsmit J, Michael NL. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys Nature 482(7383):89-93 2012 [PMID: 22217938]
  46. Macphail CL, Sayles JN, Cunningham W, Newman PA. Perceptions of Sexual Risk Compensation Following Posttrial HIV Vaccine Uptake Among Young South Africans Qualitative health research 2012 [PMID: 22218269]
  47. Culshaw A, Dong T, Rowland-Jones S. A two amino acid shift in position leads to a substantial difference in the pattern of processing of two HIV-1 epitopes Journal of acquired immune deficiency syndromes (1999) 2012 [PMID: 22217677]
  48. Le Saux S, Weyand CM, Goronzy JJ. Mechanisms of immunosenescence: lessons from models of accelerated immune aging Annals of the New York Academy of Sciences 1247(1):69-82 2012 [PMID: 22224726]
  49. Duggal S, Chugh TD, Duggal AK. HIV and Malnutrition: Effects on Immune System Clinical & developmental immunology 2012:784740 2012 [PMID: 22242039]
  50. Aizire J, McConnell MS, Mudiope P, Mubiru M, Matovu F, Parsons TL, Elbireer A, Nolan M, Janoff EN, Fowler MG. Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single dose nevirapine Journal of acquired immune deficiency syndromes (1999) 2012 [PMID: 22217678]
  51. Campos-Outcalt D. HPV vaccine is now routinely indicated for males The Journal of family practice 61(1):38-40 2012 [PMID: 22220294]
  52. Shoji M, Yoshizaki S, Mizuguchi H, Okuda K, Shimada M. Immunogenic comparison of chimeric adenovirus 5/35 vector carrying optimized human immunodeficiency virus clade C genes and various promoters PloS one 7(1):e30302 2012 [PMID: 22276174]
  53. Arras M, Glauser DL, Jirkof P, Rettich A, Schade B, Cinelli P, Pinschewer DD, Ackermann M. Multiparameter telemetry as a sensitive screening method to detect vaccine reactogenicity in mice PloS one 7(1):e29726 2012 [PMID: 22276127]
  54. Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, Blattner WA, Sobieszczyk M, Suriyanon V, Kalichman A, Weiner DB, Baden LR. Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults PloS one 7(1):e29231 2012 [PMID: 22242162]
  55. Reed C, Madhi SA, Klugman KP, Kuwanda L, Ortiz JR, Finelli L, Fry AM. Development of the Respiratory Index of Severity in Children (RISC) Score among Young Children with Respiratory Infections in South Africa PloS one 7(1):e27793 2012 [PMID: 22238570]
  56. Zucker DM, Choi J, Gallagher ER. Mobile Outreach Strategies for Screening Hepatitis and HIV in High-Risk Populations Public health nursing (Boston, Mass.) 29(1):27-35 2012 [PMID: 22211749]
  57. Tamamura H. Development of Anti-HIV Agents Based on Chemical Biology Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 132(1):69-78 2012 [PMID: 22214582]
  58. Tyagi M, Romerio F. Models of HIV-1 Persistence in the CD4+ T Cell Compartment: Past, Present and Future Current HIV research 2011 [PMID: 22211662]
  59. Pegu P, Helmus R, Gupta P, Tarwater P, Caruso L, Shen C, Ross T, Chen Y. Induction of Strong Anti-HIV Cellular Immunity by a Combination of Clostridium Perfringens Expressing HIV Gag and Virus Like Particles Current HIV research 2011 [PMID: 22211658]
  60. Aghasadeghi MR, Salmani AS, Sadat SM, Javadi F, Memarnejadian A, Vahabpour R, Zabihollahi R, Moshiri A, Siadat SD. Application of Outer Membrane Vesicle of Neisseria meningitides Serogroup B as a New Adjuvant to Induce Strongly Th1-Oriented Responses Against HIV-1 Current HIV research 2011 [PMID: 22211657]
  61. Abbas Z, Siddiqui AR. Management of hepatitis B in developing countries World journal of hepatology 3(12):292-299 2011 [PMID: 22216369]
  62. Teshale EH, Hu DJ. Hepatitis E: Epidemiology and prevention World journal of hepatology 3(12):285-291 2011 [PMID: 22216368]
  63. Maclean B, Hess RF, Bonvillain E, Kamate J, Dao D, Cosimano A, Hoy S. Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 102(1):47 2011 [PMID: 22273139]
  64. Bailey J. Lessons from Chimpanzee-based Research on Human Disease: The Implications of Genetic Differences Alternatives to laboratory animals : ATLA 39(6):527-540 2011 [PMID: 22243397]
  65. Kobetz E, Menard J, Hazan G, Koru-Sengul T, Joseph T, Nissan J, Barton B, Blanco J, Kornfeld J. Perceptions of HPV and Cervical Cancer among Haitian Immigrant Women: Implications for Vaccine Acceptability Education for health (Abingdon, England) 24(3):479 2011 [PMID: 22267344]
  66. Zhang HQ, Liao WT, Chen QL, Ge YB, Yang J, Zhang PP, Qi PP, Liu C, He T, Wang JH, Pan W, Cao J. [Construction, expression and immunogenicity analysis of a Tat N-terminus-deleted mutant fusion protein of human immunodeficiency virus type 1] Bing du xue bao = Chinese journal of virology / [bian ji, Bing du xue bao bian ji wei yuan hui] 27(6):580-586 2011 [PMID: 22263271]
  67. Kwong PD, Mascola JR, Nabel GJ. Rational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1 Cold Spring Harbor perspectives in medicine 1(1):a007278 2011 [PMID: 22229123]
  68. Koup RA, Douek DC. Vaccine design for CD8 T lymphocyte responses Cold Spring Harbor perspectives in medicine 1(1):a007252 2011 [PMID: 22229122]
  69. . [Experimental study of candidate vaccines against variable or quasi-species pathogenes: multiepitopic synthetic peptide antigenes and new receptor-guiding adjuvants] Patologicheskaia fiziologiia i eksperimental'naia terapiia (3):40-42 2011 [PMID: 22279739]
  70. Adhvaryu M, Vakharia B. Drug-resistant tuberculosis: emerging treatment options Clinical pharmacology : advances and applications 3:51-67 2011 [PMID: 22287857]
  71. Switzer WM, Zheng H, Simmons G, Zhou Y, Tang S, Shankar A, Kapusinszky B, Delwart EL, Heneine W. No evidence of murine leukemia virus-related viruses in live attenuated human vaccines PloS one 6(12):e29223 2011 [PMID: 22216219]
  72. Ryan SJ, Walsh PD. Consequences of non-intervention for infectious disease in african great apes PloS one 6(12):e29030 2011 [PMID: 22216162]
  73. Davis D, Koornstra W, Mortier D, Fagrouch Z, Verschoor EJ, Heeney JL, Bogers WM. Protection in Macaques Immunized with HIV-1 Candidate Vaccines Can Be Predicted Using the Kinetics of Their Neutralizing Antibodies PloS one 6(12):e28974 2011 [PMID: 22216149]

Lassa virus

  1. Goicochea MA, Zapata JC, Bryant J, Davis H, Salvato MS, Lukashevich IS. Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model Vaccine 2012 [PMID: 22234266]

Marburg virus

  1. Palma P, Romiti ML, Bernardi S, Pontrelli G, Mora N, Santilli V, Tchidjou HK, Aquilani A, Cotugno N, Alghisi F, Lucidi V, Rossi P, Douagi I. Safety and immunogenicity of a monovalent MF59(®)-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults Biologicals : journal of the International Association of Biological Standardization 2012 [PMID: 22261282]
  2. Marzi A, Feldmann H, Geisbert TW, Falzarano D. Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections Journal of bioterrorism & biodefense S1(4) 2011 [PMID: 22288023]
  3. Warfield KL, Olinger GG. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic Fever Journal of biomedicine & biotechnology 2011:984241 2011 [PMID: 22253531]

Mycobacterium tuberculosis (tuberculosis)

  1. Cottingham MG, Carroll F, Morris SJ, Turner AV, Vaughan AM, Kapulu MC, Colloca S, Siani L, Gilbert SC, Hill AV. Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors Biotechnology and bioengineering 109(3):719-728 2012 [PMID: 22252512]
  2. Cowan J, Pandey S, Filion LG, Angel JB, Kumar A, Cameron DW. Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection Clinical and experimental immunology 167(2):317-329 2012 [PMID: 22236009]
  3. . In this issue European journal of immunology 42(2):274-275 2012 [PMID: 22266713]
  4. Moyo S, Verver S, Hawkridge A, Geiter L, Hatherill M, Workman L, Ontong C, Msemburi W, Tameris M, Geldenhuys H, Mulenga H, Snowden MA, Hanekom WA, Hussey G, Mahomed H. Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 16(2):185-191 2012 [PMID: 22236918]
  5. Schwartzman K. Needles, haystacks and grails: the challenges and promise of tuberculosis vaccine trials The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 16(2):143 2012 [PMID: 22236912]
  6. Alonso-Hearn M, Molina E, Geijo M, Vazquez P, Sevilla IA, Garrido JM, Juste RA. Immunization of adult dairy cattle with a new heat-killed vaccine is associated with longer productive life prior to cows being sent to slaughter with suspected paratuberculosis Journal of dairy science 95(2):618-629 2012 [PMID: 22281327]
  7. Castillo-Martínez D, Amezcua-Guerra LM. Self-reactivity against stress-induced cell molecules: The missing link between Takayasu's arteritis and tuberculosis? Medical hypotheses 2012 [PMID: 22285197]
  8. Scriba TJ, Tameris M, Smit E, van der Merwe L, Hughes EJ, Kadira B, Mauff K, Moyo S, Brittain N, Lawrie A, Mulenga H, de Kock M, Makhethe L, van Rensburg EJ, Gelderbloem S, Veldsman A, Hatherill M, Geldenhuys H, Hill AV, Hawkridge A, Hussey GD, Hanekom WA, McShane H, Mahomed H. A phase IIa Trial of the new TB Vaccine, MVA85A, in HIV and/or M. Tuberculosis Infected Adults American journal of respiratory and critical care medicine 2012 [PMID: 22281831]
  9. Breman JG, Brandling-Bennett AD. The challenge of malaria eradication in the twenty-first century: Research linked to operations is the key Vaccine 2012 [PMID: 22284402]
  10. Enticott G, Maye D, Ilbery B, Fisher R, Kirwan J. Farmers' confidence in vaccinating badgers against bovine tuberculosis The Veterinary record 2012 [PMID: 22238199]
  11. Chegou NN, Black GF, Loxton AG, Stanley K, Essone PN, Klein MR, Parida SK, Kaufmann SH, Doherty TM, Friggen AH, Franken KL, Ottenhoff TH, Walzl G. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting BMC infectious diseases 12(1):10 2012 [PMID: 22260319]
  12. Leversen NA, Sviland L, Wiker HG, Mustafa T. Long-term persistence of BCG Pasteur in lungs of C57BL/6 mice following intranasal infection Scandinavian journal of immunology 2012 [PMID: 22239126]
  13. Hsia EC, Schluger N, Cush J, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU. Interferon-gamma release assay versus tuberculin skin test across RA, PsA, and AS patients prior to treatment with golimumab, a human anti-TNF antibody Arthritis and rheumatism 2012 [PMID: 22238071]
  14. Shang S, Shanley CA, Caraway ML, Orme EA, Henao-Tamayo M, Hascall-Dove L, Ackart D, Orme IM, Ordway DJ, Basaraba RJ. Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis Vaccine 2012 [PMID: 22244979]
  15. De Rosa SC. Vaccine applications of flow cytometry Methods (San Diego, Calif.) 2012 [PMID: 22251671]
  16. Bouhamam N, Laporte R, Boutin A, Uters M, Bremond V, Noel G, Rodier P, Minodier P. [Relationship between precariousness, social coverage, and vaccine coverage: Survey among children consulting in pediatric emergency departments in France.] Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2012 [PMID: 22226013]
  17. Rainey JJ, Lacapère F, Danovaro-Holliday MC, Mung K, Magloire R, Kananda G, Cadet JR, Lee CE, Chamouillet H, Luman ET. Vaccination Coverage in Haiti: Results from the 2009 National Survey Vaccine 2012 [PMID: 22227146]
  18. Thibeault C, Tanguay F, Lacroix C, Menzies R, Rivest P. A case of active tuberculosis in a cabin crew: the results of contact tracing Aviation, space, and environmental medicine 83(1):61-63 2012 [PMID: 22272519]
  19. Benn CS. Combining vitamin a and vaccines: convenience or conflict? Danish medical journal 59(1):B4378 2012 [PMID: 22239846]
  20. Arras M, Glauser DL, Jirkof P, Rettich A, Schade B, Cinelli P, Pinschewer DD, Ackermann M. Multiparameter telemetry as a sensitive screening method to detect vaccine reactogenicity in mice PloS one 7(1):e29726 2012 [PMID: 22276127]
  21. Zhang T, Li SY, Nuermberger EL. Autoluminescent Mycobacterium tuberculosis for Rapid, Real-Time, Non-Invasive Assessment of Drug and Vaccine Efficacy PloS one 7(1):e29774 2012 [PMID: 22253776]
  22. Shantha GP, Kumar AA, Bhise V, Sivagnanam K, Subramanian KK, Kanade P, Khanna R. Screening for latent tuberculosis in refugees with renal failure Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 23(1):8-14 2012 [PMID: 22237211]
  23. Jou R, Huang WL. Molecular diagnosis of childhood tuberculosis and infection with Bacilli Calmette-Guerin in Taiwan Journal of the Formosan Medical Association = Taiwan yi zhi 110(12):759-761 2011 [PMID: 22248829]
  24. Fujiyama R, Higuchi J, Shirai C, Kawakami Y, Iwamoto T, Suzuki K, Okada Z, Sakatani M, Mori T, Wakabayashi I. [Comparison of conventional tuberculin skin test and QFT-2G, a new method for diagnosis of tuberculosis infection, with the use of the contact score] Kekkaku : [Tuberculosis] 86(11):869-877 2011 [PMID: 22250466]
  25. Komukai J, Matsumoto K, Tomihara A, Miyake Y, Tatsumi T, Arima K, Danno K, Hirota S, Yoshida H, Koda S, Terakawa K, Shimouchi A. [Comparative performance of tuberculin skin test and QuantiFERON TB-gold in contact investigations for tuberculosis] Kekkaku : [Tuberculosis] 86(11):847-856 2011 [PMID: 22250463]
  26. Adhvaryu M, Vakharia B. Drug-resistant tuberculosis: emerging treatment options Clinical pharmacology : advances and applications 3:51-67 2011 [PMID: 22287857]
  27. Whelan AO, Villarreal-Ramos B, Vordermeier HM, Hogarth PJ. Development of an Antibody to Bovine IL-2 Reveals Multifunctional CD4 T(EM) Cells in Cattle Naturally Infected with Bovine Tuberculosis PloS one 6(12):e29194 2011 [PMID: 22216206]
  28. Dosanjh DP, Bakir M, Millington KA, Soysal A, Aslan Y, Efee S, Deeks JJ, Lalvani A. Novel M tuberculosis Antigen-Specific T-Cells Are Early Markers of Infection and Disease Progression PloS one 6(12):e28754 2011 [PMID: 22216109]

Nipah virus

  1. Chen W, Streaker ED, Russ DE, Feng Y, Prabakaran P, Dimitrov DS. Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens Biochemical and biophysical research communications 417(4):1164-1169 2012 [PMID: 22226962]

Plasmodium falciparum (Malaria)

  1. Cottingham MG, Carroll F, Morris SJ, Turner AV, Vaughan AM, Kapulu MC, Colloca S, Siani L, Gilbert SC, Hill AV. Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors Biotechnology and bioengineering 109(3):719-728 2012 [PMID: 22252512]
  2. Breman JG, Brandling-Bennett AD. The challenge of malaria eradication in the twenty-first century: Research linked to operations is the key Vaccine 2012 [PMID: 22284402]
  3. O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, Goodman AL, Edwards NJ, Reyes-Sandoval A, Bird P, Rowland R, Sheehy SH, Poulton ID, Hutchings C, Todryk S, Andrews L, Folgori A, Berrie E, Moyle S, Nicosia A, Colloca S, Cortese R, Siani L, Lawrie AM, Gilbert SC, Hill AV. Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector The Journal of infectious diseases 2012 [PMID: 22275401]
  4. Singh B, Cabrera-Mora M, Jiang J, Moreno A. A hybrid multi-stage protein vaccine induces protective immunity against murine malaria Infection and immunity 2012 [PMID: 22252877]
  5. Clark EH, Silva CJ, Weiss GH, Li S, Padilla C, Crompton PD, Hernandez JN, Branch OH. Plasmodium falciparum malaria in the low transmission Peruvian Amazon is associated with immunologic memory Infection and immunity 2012 [PMID: 22252876]
  6. Li X, Marinkovic M, Russo C, McKnight CJ, Coetzer TL, Chishti AH. Identification of a specific region of Plasmodium falciparum EBL-1 that binds to host receptor glycophorin B and inhibits merozoite invasion in human red blood cells Molecular and biochemical parasitology 2012 [PMID: 22273481]
  7. Walther B, Miles DJ, Waight P, Palmero MS, Ojuola O, Touray ES, Whittle H, van der Sande M, Crozier S, Flanagan KL. Placental malaria is associated with attenuated CD4 T-cell responses to tuberculin PPD 12 months after BCG vaccination BMC infectious diseases 12(1):6 2012 [PMID: 22243970]
  8. Sakamoto H, Takeo S, Maier AG, Sattabongkot J, Cowman AF, Tsuboi T. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes Vaccine 2012 [PMID: 22248820]
  9. Zhang VM, Chavchich M, Waters NC. Targeting Protein Kinases in the Malaria Parasite: Update of an Antimalarial Drug Target Current topics in medicinal chemistry 2012 [PMID: 22242850]
  10. Moon JJ, Suh H, Li AV, Ockenhouse CF, Yadava A, Irvine DJ. Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction Proceedings of the National Academy of Sciences of the United States of America 2012 [PMID: 22247289]
  11. Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T. Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate Vaccine 2012 [PMID: 22245309]
  12. Arnott A, Barry AE, Reeder JC. Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination Malaria journal 11(1):14 2012 [PMID: 22233585]
  13. De Rosa SC. Vaccine applications of flow cytometry Methods (San Diego, Calif.) 2012 [PMID: 22251671]
  14. Schwartz L, Brown GV, Genton B, Moorthy VS. A review of malaria vaccine clinical projects based on the WHO rainbow table Malaria journal 11(1):11 2012 [PMID: 22230255]
  15. Tanabe K, Arisue N, Palacpac NM, Yagi M, Tougan T, Honma H, Ferreira MU, Färnert A, Björkman A, Kaneko A, Nakamura M, Hirayama K, Mita T, Horii T. Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5 Vaccine 2012 [PMID: 22230587]
  16. Maclennan CA. Host defense against malaria favors Salmonella Nature medicine 18(1):21-22 2012 [PMID: 22227659]
  17. Bordbar B, Tuikue-Ndam N, Bigey P, Doritchamou J, Scherman D, Deloron P. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies Vaccine 2012 [PMID: 22226864]
  18. Ntumngia FB, Schloegel J, Barnes SJ, McHenry AM, Singh S, King CL, Adams JH. Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies Infection and immunity 2012 [PMID: 22215740]
  19. Singh Joy SD, Rosenberg K. Vaccine reduces malaria in african children The American journal of nursing 112(1):69 2012 [PMID: 22222409]
  20. Musselwhite LW, Maciag K, Lankowski A, Gretes MC, Wellems TE, Tavera G, Goulding RE, Guillen E. First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium The American journal of tropical medicine and hygiene 86(1):65-74 2012 [PMID: 22232453]
  21. Smith T, Ross A, Maire N, Chitnis N, Studer A, Hardy D, Brooks A, Penny M, Tanner M. Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine PLoS medicine 9(1):e1001157 2012 [PMID: 22272189]
  22. Arras M, Glauser DL, Jirkof P, Rettich A, Schade B, Cinelli P, Pinschewer DD, Ackermann M. Multiparameter telemetry as a sensitive screening method to detect vaccine reactogenicity in mice PloS one 7(1):e29726 2012 [PMID: 22276127]
  23. Gitau EN, Tuju J, Stevenson L, Kimani E, Karanja H, Marsh K, Bull PC, Urban BC. T-Cell Responses to the DBLα-Tag, a Short Semi-Conserved Region of the Plasmodium falciparum Membrane Erythrocyte Protein 1 PloS one 7(1):e30095 2012 [PMID: 22272280]
  24. Ord RL, Rodriguez M, Yamasaki T, Takeo S, Tsuboi T, Lobo CA. Targeting Sialic Acid Dependent and Independent Pathways of Invasion in Plasmodium falciparum PloS one 7(1):e30251 2012 [PMID: 22253925]
  25. Bordbar B, Gnidehou S, Ndam NT, Doritchamou J, Moussiliou A, Quiviger M, Deloron P, Scherman D, Bigey P. Electroporation-mediated genetic vaccination for antigen mapping: Application to Plasmodium falciparum VAR2CSA protein Bioelectrochemistry (Amsterdam, Netherlands) 2011 [PMID: 22265101]
  26. Goodman AL, Blagborough AM, Biswas S, Wu Y, Hill AV, Sinden RE, Draper SJ. A viral vectored prime-boost immunization regime targeting the malaria pfs25 antigen induces transmission-blocking activity PloS one 6(12):e29428 2011 [PMID: 22216279]

Salmonella

  1. Nguyen AH, Molineux IJ, Springman R, Bull JJ. Multiple genetic pathways to similar fitness limits during viral adaptation to a new host Evolution; international journal of organic evolution 66(2):363-374 2012 [PMID: 22276534]
  2. Dewaele I, Van Meirhaeghe H, Rasschaert G, Vanrobaeys M, De Graef E, Herman L, Ducatelle R, Heyndrickx M, De Reu K. Persistent Salmonella Enteritidis environmental contamination on layer farms in the context of an implemented national control program with obligatory vaccination Poultry science 91(2):282-291 2012 [PMID: 22252339]
  3. Hegazy WA, Xu X, Metelitsa L, Hensel M. Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens Infection and immunity 2012 [PMID: 22252866]
  4. Pan Z, Cong Q, Geng S, Fang Q, Kang X, You M, Jiao X. Flagellin from Recombinant Attenuated Salmonella Typhimurium reveals a fundamental role in the Chicken Innate Immunity Clinical and vaccine immunology : CVI 2012 [PMID: 22237893]
  5. Gnazzo V, Cebrian I, Langellotti C, Chabalgoity J, Mongini C, Quattrocchi V, Zamorano P. Immunogenicity of a Bovine Herpes Virus I Peptide Expressed in Tandem Copies in Attenuated Salmonella Viral immunology 2012 [PMID: 22233252]
  6. Maclennan CA. Host defense against malaria favors Salmonella Nature medicine 18(1):21-22 2012 [PMID: 22227659]
  7. Olivier M, Foret B, Le Vern Y, Guilloteau LA. Capacities of Migrating CD1b Lymph Dendritic Cells to Present Salmonella Antigens to Naive T Cells PloS one 7(1):e30430 2012 [PMID: 22279590]
  8. Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, Ochieng JB, Wamola N, Bigogo GM, Awiti G, Tabu CW, Burke H, Williamson J, Oundo JO, Mintz ED, Feikin DR. Population-based incidence of typhoid Fever in an urban informal settlement and a rural area in kenya: implications for typhoid vaccine use in Africa PloS one 7(1):e29119 2012 [PMID: 22276105]
  9. Yang X, Suo Z, Thornburg T, Holderness K, Cao L, Lim T, Walters N, Kellerman L, Loetterle L, Avci R, Pascual DW. Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella Virulence 3(1) 2012 [PMID: 22286706]
  10. Mohler VL, Heithoff DM, Mahan MJ, Hornitzky MA, Thomson PC, House JK. Development of a novel in-water vaccination protocol for DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine in adult sheep Vaccine 2011 [PMID: 22214887]
  11. Chaung HC, Cheng LT, Hung LH, Tsai PC, Skountzou I, Wang B, Compans RW, Lien YY. Salmonella flagellin enhances mucosal immunity of avian influenza vaccine in chickens Veterinary microbiology 2011 [PMID: 22226542]
  12. Schroeder J, Brown N, Kaye P, Aebischer T. Single Dose Novel Salmonella Vaccine Enhances Resistance against Visceralizing L. major and L. donovani Infection in Susceptible BALB/c Mice PLoS neglected tropical diseases 5(12):e1406 2011 [PMID: 22216363]
  13. . [Experimental study of candidate vaccines against variable or quasi-species pathogenes: multiepitopic synthetic peptide antigenes and new receptor-guiding adjuvants] Patologicheskaia fiziologiia i eksperimental'naia terapiia (3):40-42 2011 [PMID: 22279739]
  14. Wisner AL, Potter AA, Köster W. Effect of the Salmonella Pathogenicity Island 2 Type III Secretion System on Salmonella Survival in Activated Chicken Macrophage-Like HD11 Cells PloS one 6(12):e29787 2011 [PMID: 22216355]

Staphylococcal enterotoxin B

  1. Coe CL, Lubach GR, Kinnard J. Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination Age (Dordrecht, Netherlands) 2012 [PMID: 22231440]

Variola major (Smallpox)

  1. Domenico J, Lucas JJ, Fujita M, Gelfand EW. Susceptibility to Vaccinia Virus Infection and Spread in Mice Is Determined by Age at Infection, Allergen Sensitization and Mast Cell Status International archives of allergy and immunology 158(2):196-205 2012 [PMID: 22286752]
  2. Breman JG, Brandling-Bennett AD. The challenge of malaria eradication in the twenty-first century: Research linked to operations is the key Vaccine 2012 [PMID: 22284402]
  3. Tan X, Chun S, Pablo J, Felgner P, Liang X, Davies DH. Failure of smallpox vaccine to take in vaccinia-naive individuals is related to differences in antibody profiles before vaccination, not after Clinical and vaccine immunology : CVI 2012 [PMID: 22258709]
  4. Kupper TS. Old and New: Recent Innovations in Vaccine Biology and Skin T Cells The Journal of investigative dermatology 2012 [PMID: 22237702]
  5. Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination Trends in microbiology 2012 [PMID: 22239910]
  6. Garcel A, Fauquette W, Dehouck MP, Crance JM, Favier AL. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage Vaccine 2012 [PMID: 22227123]

Vibrio cholerae

  1. Arifuzzaman M, Ahmed T, Rahman MA, Chowdhury F, Rashu R, Khan AI, Larocque RC, Harris JB, Bhuiyan TR, Ryan ET, Calderwood SB, Qadri F. Individuals with Le(a+b-) Blood Group Have Increased Susceptibility to Symptomatic Vibrio cholerae O1 Infection PLoS neglected tropical diseases 5(12):e1413 2011 [PMID: 22216364]

Yersinia pestis (Plague)

  1. Miller NC, Quenee LE, Elli D, Ciletti NA, Schneewind O. Polymorphisms in the lcrV gene of Yersinia enterocolitica and their effect on plague protective immunity Infection and immunity 2012 [PMID: 22252870]


** Click HERE to see the latest publications in this month.